Generalization Error in Deep Learning

Deep learning models have lately shown great performance in various fields such as computer vision, speech recognition, speech translation, and natural language processing. However, alongside their state-of-the-art performance, it is still generally unclear what is the source of their generalization ability. Thus, an important question is what makes deep neural networks able to generalize well from the training set to new data. In this article, we provide an overview of the existing theory and bounds for the characterization of the generalization error of deep neural networks, combining both classical and more recent theoretical and empirical results

Multiparametric magnetic resonance imaging of normal and degenerative lumbar intervertebral discs

Magnetic resonance imaging (MRI) has been shown to improve the diagnosis and management of patients with intervertebral disc (IVD) related disorders. Multiparametric MRI offers the possibility of noninvasively assessing multiple aspects of pathophysiological processes that exist simultaneously, thereby further assisting in patient treatment management. The purpose of this study is to determine the correlation between relaxation parameters (T1ρ and T2), diffusion properties including fractional anisotropy (FA) and mean diffusivity (MD) measured by diffusion tensor imaging (DTI) and various clinical findings in human IVD. Our results suggest that each parameter may attribute different sensitivity to tissue properties.postprin

Ultrashort time-to-echo MRI of the cartilagenous endplate and relationship to degenerative disc disease and schmorl's nodes

Session - The Short of ItINTRODUCTION: The vertebral endplate is composed of an inner bony and outer cartilaginous endplates (CEP). The CEP supplies the intervertebral disc (IVD) with nutrients and metabolites, and is instrumental for metabolism, exchange of waste products and biomechanics of the disc 1. Lumbar disc degeneration on MRI is a risk factor for the development of low back pain 2. It has been previously hypothesized that changes in disc mechanics may be initiated by damage to the endplate 3, 4. Similarly, CEP defects may be involved in the formation of Schmorl’s nodes (SNs) (i.e. invagination of IVD material into the adjacent endplates) 5, which associated with severity of lumbar disc degeneration 6. The ultrashort time-to-echo (UTE) MRI is an imaging technique that enables improved visualization of tissues with short T2 relaxation that appear dark in signal on conventional T2-weighted (T2W) imaging. By employing this technique in the lumbar spine, we believe that the CEP, which appears hypointense in T2W MRI, may be observed as continuous high-signal and may thus be differentiated from the bony endplate. Although cadaveric studies have addressed the feasibility of UTE in assessing the CEP 7, studies addressing such technology in live human subjects …published_or_final_versionThe 19th Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine (ISMRM 2011), Montreal, QC., 7-13 May 2011. In Proceedings of the 19th ISMRM, 2011, v. 19, p. 57

Ultrashort time-to-echo MRI of the cartilagenous endplate & relationship to degenerative disc disease & Schmorl’s nodes

Session - The Short of It: no. 570Early diagnosis of CEP defects by UTE technique may provide useful information for understanding the pathogenesis of each of DDD and Schmorl¡¦s nodes (SN). The objective of this study was to assess CEP integrity in normal IVD levels, levels with degenerated IVDs and levels with SNs. Based on the UTE images, CEP defects were defined as discontinuity of high signal over 4 consecutive slices. Results showed that CEP defects were found to have a 4.5 fold increased likelihood of having DDD. No association between CEP defects and SNs was established. The effects of age and CEP defects were found to be level dependent. (abstract by publisher)postprin

Hmong Adults Self-Rated Oral Health: A Pilot Study

Since 1975, the Hmong refugee population in the U.S. has increased over 200%. However, little is known about their dental needs or self-rated oral health (SROH). The study aims were to: (1) describe the SROH, self-rated general health (SRGH), and use of dental/physician services; and (2) identify the factors associated with SROH among Hmong adults. A cross-sectional study design with locating sampling methodology was used. Oral health questionnaire was administered to assess SROH and SRGH, past dental and physician visits, and language preference. One hundred twenty adults aged 18–50+ were recruited and 118 had useable information. Of these, 49% rated their oral health as poor/fair and 30% rated their general health as poor/fair. Thirty-nine percent reported that they did not have a regular source of dental care, 46% rated their access to dental care as poor/fair, 43% visited a dentist and 66% visited a physician within the past 12 months. Bivariate analyses demonstrated that access to dental care, past dental visits, age and SRGH were significantly associated with SROH (P \u3c 0.05). Multivariate analyses demonstrated a strong association between access to dental care and good/excellent SROH. About half of Hmong adults rated their oral health and access to dental care as poor. Dental insurance, access to dental care, past preventive dental/physician visits and SRGH were associated with SROH

F-18 Fluorodeoxyglucose non-avid hepatosplenic T cell lymphoma: a diagnostic pitfall

published_or_final_versionSpringer Open Choice, 21 Feb 201

Assessment of the neurocentral synchondrosis in pediatric spines and the "developmental" etiology of Schmorl's nodes

Special Poster: no. SP13INTRODUCTION: Schmorl's nodes of the thoraco-lumbar region have been associated with the presence and severity of disc degeneration in adults. The etiology of Schmorl's nodes remains precarious; however a unique multilevel phenotype of 'kissing' nodes seems to suggest a developmental origin. The neurocentral synchondrosis (NCS) are cartilaginous growth plates near the neural arch ossification centres in a growing vertebrae that may play a direct role in the development of endplate abnormalities, such as Schmorl's nodes. This study assessed the NCS in ...postprin

A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease

BACKGROUND: Cervical cancer is the most common female malignancy in the developing nations and the third most common cancer in women globally. An effective, inexpensive and self-applied topical treatment would be an ideal solution for treatment of screen-detected, pre-invasive cervical disease in low resource settings. METHODS: Between 01/03/2013 and 01/08/2013, women attending Kenyatta National Hospital's Family Planning and Gynaecology Outpatients clinics were tested for HIV, HPV (Cervista®) and liquid based cervical cytology (LBC -ThinPrep®). HIV negative women diagnosed as high-risk HPV positive with high grade squamous intraepithelial lesions (HSIL) were examined by colposcopy and given a 2 week course of 1 capsule of Lopimune (CIPLA) twice daily, to be self-applied as a vaginal pessary. Colposcopy, HPV testing and LBC were repeated at 4 and 12 weeks post-start of treatment with a final punch biopsy at 3 months for histology. Primary outcome measures were acceptability of treatment with efficacy as a secondary consideration. RESULTS: A total of 23 women with HSIL were treated with Lopimune during which time no adverse reactions were reported. A maximum concentration of 10 ng/ml of lopinavir was detected in patient plasma 1 week after starting treatment. HPV was no longer detected in 12/23 (52.2%, 95%CI: 30.6-73.2%). Post-treatment cytology at 12 weeks on women with HSIL, showed 14/22 (63.6%, 95%CI: 40.6-82.8%) had no dysplasia and 4/22 (18.2%, 95%CI: 9.9-65.1%) were now low grade demonstrating a combined positive response in 81.8% of women of which 77.8% was confirmed by histology. These data are supported by colposcopic images, which show regression of cervical lesions. CONCLUSIONS: These results demonstrate the potential of Lopimune as a self-applied therapy for HPV infection and related cervical lesions. Since there were no serious adverse events or detectable post-treatment morbidity, this study indicates that further trials are clearly justified to define optimal regimes and the overall benefit of this therapy. TRIAL REGISTRATION: ISRCTN Registry 48776874

Alcohol imagery on New Zealand television

BACKGROUND: To examine the extent and nature of alcohol imagery on New Zealand (NZ) television, a content analysis of 98 hours of prime-time television programs and advertising was carried out over 7 consecutive days' viewing in June/July 2004. The main outcome measures were number of scenes in programs, trailers and advertisements depicting alcohol imagery; the extent of critical versus neutral and promotional imagery; and the mean number of scenes with alcohol per hour, and characteristics of scenes in which alcohol featured. RESULTS: There were 648 separate depictions of alcohol imagery across the week, with an average of one scene every nine minutes. Scenes depicting uncritical imagery outnumbered scenes showing possible adverse health consequences of drinking by 12 to 1. CONCLUSION: The evidence points to a large amount of alcohol imagery incidental to storylines in programming on NZ television. Alcohol is also used in many advertisements to market non-alcohol goods and services. More attention needs to be paid to the extent of alcohol imagery on television from the industry, the government and public health practitioners. Health education with young people could raise critical awareness of the way alcohol imagery is presented on television

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

Background Patients with advanced midgut neuroendocrine tumors who have had disease progression during first-line somatostatin analogue therapy have limited therapeutic options. This randomized, controlled trial evaluated the efficacy and safety of lutetium-177 (177Lu)-Dotatate in patients with advanced, progressive, somatostatin-receptor-positive midgut neuroendocrine tumors. Methods We randomly assigned 229 patients who had well-differentiated, metastatic midgut neuroendocrine tumors to receive either 177Lu-Dotatate (116 patients) at a dose of 7.4 GBq every 8 weeks (four intravenous infusions, plus best supportive care including octreotide long-acting repeatable [LAR] administered intramuscularly at a dose of 30 mg) (177Lu-Dotatate group) or octreotide LAR alone (113 patients) administered intramuscularly at a dose of 60 mg every 4 weeks (control group). The primary end point was progression-free survival. Secondary end points included the objective response rate, overall survival, safety, and the side-effect profile. The final analysis of overall survival will be conducted in the future as specified in the protocol; a prespecified interim analysis of overall survival was conducted and is reported here. Results At the data-cutoff date for the primary analysis, the estimated rate of progression-free survival at month 20 was 65.2% (95% confidence interval [CI], 50.0 to 76.8) in the 177Lu-Dotatate group and 10.8% (95% CI, 3.5 to 23.0) in the control group. The response rate was 18% in the 177Lu-Dotatate group versus 3% in the control group (P<0.001). In the planned interim analysis of overall survival, 14 deaths occurred in the 177Lu-Dotatate group and 26 in the control group (P=0.004). Grade 3 or 4 neutropenia, thrombocytopenia, and lymphopenia occurred in 1%, 2%, and 9%, respectively, of patients in the 177Lu-Dotatate group as compared with no patients in the control group, with no evidence of renal toxic effects during the observed time frame. Conclusions Treatment with 177Lu-Dotatate resulted in markedly longer progression-free survival and a significantly higher response rate than high-dose octreotide LAR among patients with advanced midgut neuroendocrine tumors. Preliminary evidence of an overall survival benefit was seen in an interim analysis; confirmation will be required in the planned final analysis. Clinically significant myelosuppression occurred in less than 10% of patients in the 177Lu-Dotatate group. (Funded by Advanced Accelerator Applications; NETTER-1 ClinicalTrials.gov number, NCT01578239 ; EudraCT number 2011-005049-11